Shawna Kraft, PharmD
College of Pharmacy
428 Church St
Ann Arbor, MI 48109-1065
Summary
Shawna Kraft earned her PharmD from the University of Michigan College of Pharmacy and completed a PGY-1 and PGY-2 in oncology at U-M Hospitals and Health Centers (UMHHC). She took care of inpatients as a clinical specialist in hematology/oncology for several years before assuming her current role in the clinic setting at U-M’s Comprehensive Cancer Center.
Professor Kraft provides didactic education on several topics, including oncologic and non-oncologic pain management, breast cancer, leukemias and lymphomas. She presents regularly at local, regional, and national conferences on multiple myeloma, oral chemotherapy, and symptom management topics. She is a board certified oncology pharmacist and the program director for the PGY-2 in oncology at UMHHC. She is also a member of the U-M College of Pharmacy Board of Governors and an active member of the American Society of Health-System Pharmacists, American College of Clinical Pharmacy, Hematology/Oncology Pharmacists Association, Michigan Society of Health System Pharmacists, and Michigan Pharmacists Association.
Research Interests
Supportive care and symptom management in patients with cancer
Medical marijuana, oral chemotherapy, and antidepressants in cancer patients
Awards
- 2024 2023-2024 Phi Delta Chi Faculty Appreciation Award , Phi Delta Chi at UM
- 2022 2022 Michigan Center for IPE Award for Innovation and Excellence , IPE Center
- 2019 MSHP President's Award, MSHP
- 2017 P3 Faculty appreciation award, Student (sponsored by PDC)
Selected Publications
Kraft S, Baker N, Carpenter J, Bostwick J. Procarbazine and antidepressants: A retrospective review of the risk of serotonin toxicity. Psych-Oncology (accepted, undergoing revisions).
Koselke E, Kraft S. Chemotherapy induced diarrhea: Options for treatment and prevention. J Hem/Onc Pharm. 2012 Dec; 2(4):143-151.
Koselke E, Kraft S, Smith J, Nagel J. Evaluation of the effect of obesity on voriconazole serum concentrations. J Antimicrob Chemotherapy. 2012 Aug 21. [Epub ahead of print].
Kraft SL, Johnson CE, Tyler R. Stability of oral liquid preparation of thalidomide 20 mg/mL in syrup. Am J Health Syst Pharm. 2012 Jan 1; 69(1):56-8.